Absolute Quantification of Selected Proteins in the Human Osteoarthritic Secretome

Peffers, Mandy J.; Beynon, Robert J.; Clegg, Peter D.
October 2013
International Journal of Molecular Sciences;Oct2013, Vol. 14 Issue 10, p20658
Academic Journal
Osteoarthritis (OA) is characterized by a loss of extracellular matrix which is driven by catabolic cytokines. Proteomic analysis of the OA cartilage secretome enables the global study of secreted proteins. These are an important class of molecules with roles in numerous pathological mechanisms. Although cartilage studies have identified profiles of secreted proteins, quantitative proteomics techniques have been implemented that would enable further biological questions to be addressed. To overcome this limitation, we used the secretome from human OA cartilage explants stimulated with IL-1β and compared proteins released into the media using a label-free LC-MS/MS-based strategy. We employed QconCAT technology to quantify specific proteins using selected reaction monitoring. A total of 252 proteins were identified, nine were differentially expressed by IL-1 β stimulation. Selected protein candidates were quantified in absolute amounts using QconCAT. These findings confirmed a significant reduction in TIMP-1 in the secretome following IL-1β stimulation. Label-free and QconCAT analysis produced equivocal results indicating no effect of cytokine stimulation on aggrecan, cartilage oligomeric matrix protein, fibromodulin, matrix metalloproteinases 1 and 3 or plasminogen release. This study enabled comparative protein profiling and absolute quantification of proteins involved in molecular pathways pertinent to understanding the pathogenesis of OA.


Related Articles

  • ProtQuant: a tool for the label-free quantification of MudPIT proteomics data. Bridges, Susan M.; Magee, G. Bryce; Nan Wang; Williams, W. Paul; Burgess, Shane C.; Nanduri, Bindu // BMC Bioinformatics;2007 Supplement 7, Vol. 8, pS24 

    Background: Effective and economical methods for quantitative analysis of high throughput mass spectrometry data are essential to meet the goals of directly identifying, characterizing, and quantifying proteins from a particular cell state. Multidimensional Protein Identification Technology...

  • High Protein Level Reveals Arthritis Before X-rays Show Damage.  // Nutrition Health Review: The Consumer's Medical Journal;2001, Issue 81, p15 

    Focuses on the increasing cartilage oligomeric matrix protein among patients with hip/knee osteoarthritis in North Carolina. Alleviation of blood flow; Revelation of joint damage; Occurrence of suffering from degenerative condition swells.

  • Proteomic Analyses of Proteins Differentially Expressed in Recurrent and Primary Pterygia. Kanamoto, Takashi; Souchelnytskyi, Nazariy; Toda, Ryotaro; Rimayanti, Ulfah; Kiuch, Yoshiaki // Journal of Proteomics & Bioinformatics;2011, Vol. 4 Issue 3, p58 

    We describe a proteomic approach to identify proteins which may be involved in the recurrence of pterygia. Tissues from a recurrent pterygium and from a primary pterygium were surgically resected and were analyzed by proteomics to identify proteins that were significantly up- or down-regulated....

  • Glucosamine and caveat emptor. Luft, Friedrich // Journal of Molecular Medicine;Nov2013, Vol. 91 Issue 11, p1233 

    The article focuses on glucosamine and its caveat therapeutic role. It mentions that glucosamine is a monosaccharide and a precursor in the biochemical synthesis of glycosylated lipids and proteins. It adds that glucosamine is also beneficial in the treatment of osteoarthritis where the main...

  • Targeting ADAM12 in Human Disease: Head, Body or Tail? Jacobsen, J.; Wewer, U. M. // Current Pharmaceutical Design;7/11/2009, Vol. 15 Issue 20, p2300 

    ADAM12/meltrin a is a type I transmembrane multidomain protein involved in tumor progression and other severe diseases, including osteoarthritis, and as such could be considered as a potential drug target. In addition to protease activity, ADAM12 possesses cell binding and cell signaling...

  • Inhibition of Matrix Metalloproteinases Enhances In Vitro Repair of the Meniscus. Amy McNulty // Clinical Orthopaedics & Related Research;Jun2009, Vol. 467 Issue 6, p1557 

    Abstract  Damage or injury of the meniscus is associated with onset and progression of knee osteoarthritis (OA). The intrinsic repair capacity of the meniscus is inhibited by inflammatory cytokines, such as interleukin-1 (IL-1). Using an in vitro meniscal repair model system, we examined...

  • Lectin Glycoarray Technologies for Nanoscale Biomedical Detection. Ki Chan; Tzi Bun Ng // Protein & Peptide Letters;Nov2010, Vol. 17 Issue 11, p1417 

    No abstract available.

  • Regulation of matrix metalloproteinase MT1-MMP/MMP-2 in cardiac fibroblasts by TGF-�1 involves furin-convertase. Stawowy, Philipp; Margeta, Christian; Kallisch, Heike; Seidah, Nabil G.; Chr�tien, Michel; Fleck, Eckart; Graf, Kristof // Cardiovascular Research;Jul2004, Vol. 63 Issue 1, p87 

    Objective: Heart failure is characterized by an imbalance of matrix synthesis/turnover, finally resulting in fibrosis. Cardiac myocytes and fibroblasts play a pivotal role in the remodeling process. Cardiac remodeling involves the expression of TGF-�1 and matrix metalloproteinases (MMPs) in...

  • Protection of Bovine Chondrocyte Phenotype by Heat Inactivation of Allogeneic Serum in Monolayer Expansion Cultures. Matmati, Mourad; Ng, Tat; Rosenzweig, Derek; Quinn, Thomas // Annals of Biomedical Engineering;May2013, Vol. 41 Issue 5, p894 

    Cartilage defects can be addressed with replacement strategies such as autologous chondrocyte implantation (ACI). Expansion of autologous chondrocytes in vitro is an essential step to obtain the necessary cell numbers required for ACI. A major problem with this approach is dedifferentiation of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics